Green design "bioinspired disassembly-reassembly strategy" applied for improved tumor-targeted anticancer drug delivery

被引:36
作者
Wang, Ruoning [1 ]
Gu, Xiaochen [2 ]
Zhou, Jianping [1 ]
Shen, Lingjia [3 ]
Yin, Lifang [1 ]
Hua, Peiying [1 ]
Ding, Yang [1 ]
机构
[1] China Pharmaceut Univ, Dept Pharmaceut, State Key Lab Nat Med, 24 Tongjiaxiang, Nanjing 210009, Peoples R China
[2] Univ Manitoba, Coll Pharm, 750 McDermot Ave, Winnipeg, MB R3E 0T5, Canada
[3] Jiangsu Hengrui Med CO LTD, Natl Engn & Res Ctr Target Drugs, 7 Kunlun Shan Rd, Lianyungang 222000, Peoples R China
基金
中国国家自然科学基金;
关键词
Green designed lipoprotein-like nanoparticles; Bioinspired disassembly-reassembly strategy; Multi-targeting system; Enhanced anticancer efficacy; Safety profile; HIGH-DENSITY-LIPOPROTEIN; POLYMERIC NANOPARTICLES; SIRNA DELIVERY; LUNG-CANCER; PACLITAXEL; THERAPY; NANOCARRIERS; LIPOSOMES; SYSTEMS;
D O I
10.1016/j.jconrel.2016.05.055
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In this study, a simple and green approach 'bioinspired disassembly-reassembly strategy' was employed to reconstitute lipoprotein nanoparticles (RLNs) using whole-components of endogenous ones (contained dehydrated human lipids and native apolipoproteins). These RLNs were engineered to mimic the configuration and properties of natural lipoproteins for efficient drug delivery. In testing therapeutic targeting tomicrotubules, paclitaxel (PTX) was reassembled into RLNs to achieve improved targeted anti-carcinoma treatment and minimize adverse effects, demonstrating ultimately more applicable than HDL-like particles which are based on exogenous lipid sources. We have characterized that apolipoprotein-decoration of PTX-loaded RLNs (RLNs-PTX) led to favoring uniformly dispersed distribution, increasing PTX-encapsulation with a sustained-release pattern, while enhancing biostability during blood circulation. The innate biological RLNs induced efficient intracellular trafficking of cargos in situ via multi-targeting mechanisms, including scavenger receptor class B type I (SR-BI)-mediated direct transmembrane delivery, as well as other lipoprotein-receptors associated endocytic pathways. The resulting anticancer treatment from RLNs-PTX was demonstrated a half-maximal inhibitory concentration of 0.20 mu g/mL, cell apoptosis of 18.04% 24 h post-incubation mainly arresting G2/M cell cycle in vitro, and tumor weight inhibition of 70.51% in vivo. Collectively, green-step assembly-based RLNs provided an efficient strategy for mediating tumor-targeted accumulation of PTX and enhanced anticancer efficacy. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:134 / 146
页数:13
相关论文
共 44 条
  • [1] MLL Histone Methylases Regulate Expression of HDLR-SR-B1 in Presence of Estrogen and Control Plasma Cholesterol in Vivo
    Ansari, Khairul I.
    Kasiri, Sahba
    Hussain, Imran
    Bobzean, Samara A. Morris
    Perrotti, Linda I.
    Mandal, Subhrangsu S.
    [J]. MOLECULAR ENDOCRINOLOGY, 2013, 27 (01) : 92 - 105
  • [2] Applications of phototheranostic nanoagents in photodynamic therapy
    Bhaumik, Jayeeta
    Mittal, Amit Kumar
    Banerjee, Avik
    Chisti, Yusuf
    Banerjee, Uttam Chand
    [J]. NANO RESEARCH, 2015, 8 (05) : 1373 - 1394
  • [3] Modern methods for delivery of drugs across the blood-brain barrier
    Chen, Yan
    Liu, Lihong
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (07) : 640 - 665
  • [4] Nanocrystal Core High-Density Lipoproteins: A Multimodality Contrast Agent Platform
    Cormode, David P.
    Skajaa, Torjus
    van Schooneveld, Matti M.
    Koole, Rolf
    Jarzyna, Peter
    Lobatto, Mark E.
    Calcagno, Claudia
    Barazza, Alessandra
    Gordon, Ronald E.
    Zanzonico, Pat
    Fisher, Edward A.
    Fayad, Zahi A.
    Mulder, Willem J. M.
    [J]. NANO LETTERS, 2008, 8 (11) : 3715 - 3723
  • [5] Modified natural nanoparticles as contrast agents for medical imaging
    Cormode, David P.
    Jarzyna, Peter A.
    Mulder, Willem J. M.
    Fayad, Zahi A.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (03) : 329 - 338
  • [6] Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery
    Damiano, Marina G.
    Mutharasan, R. Kannan
    Tripathy, Sushant
    McMahon, Kaylin M.
    Thaxton, C. Shad
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (05) : 649 - 662
  • [7] Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis
    Ding, Yang
    Wang, Yazhe
    Zhou, Jianping
    Gu, Xiaochen
    Wang, Wei
    Liu, Congyan
    Bao, Xiuli
    Wang, Cheng
    Li, Yuanru
    Zhang, Qiang
    [J]. BIOMATERIALS, 2014, 35 (25) : 7214 - 7227
  • [8] A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy
    Ding, Yang
    Wang, Wei
    Feng, Meiqing
    Wang, Yu
    Zhou, Jianping
    Ding, Xuefang
    Zhou, Xin
    Liu, Congyan
    Wang, Ruoning
    Zhang, Qiang
    [J]. BIOMATERIALS, 2012, 33 (34) : 8893 - 8905
  • [9] An overview of the analytical characterization of nanostructured drug delivery systems: Towards green and sustainable pharmaceuticals: A review
    Domingo, Concepcion
    Saurina, Javier
    [J]. ANALYTICA CHIMICA ACTA, 2012, 744 : 8 - 22
  • [10] Synthetic high-density lipoprotein-like nanoparticles for cancer therapy
    Foit, Linda
    Giles, Francis J.
    Gordon, Leo I.
    Thaxton, Colby Shad
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (01) : 27 - 34